Peter D. Kies
2017
In 2017, Peter D. Kies earned a total compensation of $1.4M as Chief Financial Officer at Inovio Pharmaceuticals, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $137,530 |
|---|---|
| Option Awards | $437,586 |
| Salary | $452,777 |
| Stock Awards | $409,484 |
| Other | $10,010 |
| Total | $1,447,387 |
Kies received $452.8K in salary, accounting for 31% of the total pay in 2017.
Kies also received $137.5K in non-equity incentive plan, $437.6K in option awards, $409.5K in stock awards and $10K in other compensation.
Rankings
In 2017, Peter D. Kies' compensation ranked 7,178th out of 14,666 executives tracked by ExecPay. In other words, Kies earned more than 51.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,178 out of 14,666 | 51st |
Division Manufacturing | 2,668 out of 5,768 | 54th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 344 out of 856 | 60th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 174 out of 528 | 67th |
Industry Surgical and Medical Instruments and Apparatus | 106 out of 333 | 68th |
Source: SEC filing on March 28, 2018.
Kies' colleagues
We found three more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2017.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019